Phase 3 Uveal Melanoma Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Adjuvant Tebentafusp in High Risk Ocular Melanoma
Uveal Melanoma
European Organisation for Research and Treatment of Cancer - EORTC290 enrolled14 locationsNCT06246149
Recruiting
Phase 3
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma
Uveal MelanomaChoroidal MelanomaIndeterminate Lesions+1 more
Aura Biosciences100 enrolled71 locationsNCT06007690
Recruiting
Phase 2Phase 3
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Metastatic Uveal Melanoma
Replimune Inc.280 enrolled31 locationsNCT06581406
Recruiting
Phase 3
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Uveal Melanoma
IDEAYA Biosciences520 enrolled87 locationsNCT07015190
Recruiting
Phase 3
Adjuvant Melatonin for Uveal Melanoma
Uveal MelanomaEye Cancer, Intraocular MelanomaUveal Melanoma, Posterior, Medium/Large Size
Gustav Stalhammar100 enrolled1 locationNCT05502900
Recruiting
Phase 3
PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
Liver MetastasesUveal Melanoma
Vastra Gotaland Region40 enrolled6 locationsNCT06519266